Pharmafile Logo
Pharmafocus logo
Advanced Search

Genentech

Showing 15 posts of 91 posts found.

23andme image

23andMe to move into drug development

March 16, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google

The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …

News
Amgen image

Late-stage successes for Amgen and Roche

February 5, 2015
Sales and Marketing Amgen, Bendamustine, Gazyva, Genentech, Humira, Levact, Napp, Roche, adalimumab, obinutuzumab

Roche and Amgen have both posted successful late-stage trial results that they say will contribute to their applications for regulatory …

News
Genentech image

Genentech and Human Longevity ink genomics deal

January 19, 2015
Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity

Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …

News
Roche image

Roche buys French biotech for €470 million

January 19, 2015
Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos

Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …

News
Roche image

Roche stakes $1 billion in cancer gene research firm

January 12, 2015
Research and Development, Sales and Marketing Cancer, Foundation Medicine, Genentech, Roche, genomics, jp morgan

Roche has announced a huge billion-dollar investment in the cancer genomics research firm Foundation Medicine. Timed with the beginning of …

News
23andme image

Genentech makes $10m gene testing outlay

January 8, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …

News
philippe_bishop_gilead

Gilead secures senior head from Genentech

December 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Gilead, Philippe Bishop

Dr Philippe Bishop is joining the California-based biopharma firm Gilead from Genentech to be the company’s senior vice president of …

Appointment

NICE wants more Xolair data

November 19, 2014
Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab

 Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …

News
roche_glass_building

Roche pays $8.3bn for InterMune

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche

Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …

News

Mixed bag for Genentech dementia drug

July 18, 2014
Research and Development, Sales and Marketing Alzheimer's, Genentech, crenezumab, dementia

A Phase II clinical trial for Genentech’s investigational Alzheimer’s drug failed to meet its primary endpoints – but the company …

News

Novartis makes Alzheimer’s deal

July 16, 2014
Research and Development, Sales and Marketing Alzheimer's, Genentech, Novartis, bai, epstein

Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …

News
Genentech image

Genentech to buy Seragon

July 3, 2014
Sales and Marketing Genentech, Roche, breast cancer, oncology, serds

Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …

News

Genome-driven lung cancer trial launches

June 18, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

News
kadcyla image

NICE rejects Kadcyla

April 23, 2014
Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche

NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …

News
abbvie image

CLL drug achieves ‘unprecedented’ remissions

December 9, 2013
Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199

AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …

News

Latest content

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024